Tenders Are Invited For Pharmaceutical Products-Completion Of Non-Exclusive Discount Agreements According To ... in Germany

Work Detail

Pharmaceutical Products-Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V In The Period From 01.07.2025 To 30.06.2027. Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Ambroxol. The Effectiveness 30 Mg / 5 Ml Is Expressly Excluded From This Contract.,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Beclometason Dipropionat,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Clotrimazole In The Dosage Form Cr.,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Diclofenac In The Dosage Form Tmr And The Power Strength 25Mg.,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Iron (Ii) Ion In The Dosage Forms Fta And Hkp.,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Estriol In The Dosage Forms Ovu And Vcr.,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Methylprednisolone In The Dosage Forms Plh And Tab,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Midazolam In The Dosage Form.,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Quinapril Hydrochloride + Hydrochlorothiacida,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Selegilin.,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Fitinib.,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Ticlopidin.,Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Risperidone In The Daring Form Pld, Pli.

Contact Information